Abbott Reports Second-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- HSBC Downgrades IBM (IBM) to Reduce, 'Stretched Valuation'
Abbott Labs (ABT) PT Raised to $72 at Cowen
July 19, 2018 8:23 AM EDTCowen raised its price target on Abbott Labs (NYSE: ABT) to $72.00 (from $68.00) while maintaining a Outperform rating following solid Q2 results.
Analyst Joshua Jennings notes organic growth was 8%, versus 6%-7% guidance range and also north of the 7% organic rate shown in 1Q. Also, guidance was raised despite a strong dollar.
... MoreAbbott Labs (ABT) PT Raised to $70 at RBC Capital
July 19, 2018 7:16 AM EDTRBC Capital raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $67.00) while maintaining a Outperform rating.
Analyst Glenn Novarro said results again demonstrated powerful momentum across all four segments, especially outside the U.S.
... MoreAbbott Labs (ABT) PT Raised to $70 at Evercore ISI
July 18, 2018 12:19 PM EDTEvercore ISI raised its price target on Abbott Labs (NYSE: ABT) to $70.00 (from $66.00) while maintaining a Outperform rating.
What analyst Vijay Kumar liked in the quarter:
8% organic topline came in above ST and whisper expectationsNutrition came in above (~2% above ST) and... MoreAbbott (ABT) Tops Q4 EPS by 2c, Updates FY Guidance
July 18, 2018 7:47 AM EDTAbbott (NYSE: ABT) reported Q4 EPS of $0.73, $0.02 better than the analyst estimate of $0.71. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.76 billion.
GUIDANCE:
Abbott sees FY2019 EPS of $2.85-$2.91, versus the consensus of $2.86.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More